[HTML][HTML] Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference
IC Macdougall, AJ Bircher, KU Eckardt, GT Obrador… - Kidney international, 2016 - Elsevier
Before the introduction of erythropoiesis-stimulating agents (ESAs) in 1989, repeated
transfusions given to patients with end-stage renal disease caused iron overload, and the …
transfusions given to patients with end-stage renal disease caused iron overload, and the …
[HTML][HTML] Iron overload in renal failure patients: changes since the introduction of erythropoietin therapy
JW Eschbach, JW Adamson - Kidney International, 1999 - Elsevier
Iron overload in renal failure patients: Changes since the introduction of erythropoietin
therapy. Iron overload was a common complication in patients with chronic renal failure …
therapy. Iron overload was a common complication in patients with chronic renal failure …
[HTML][HTML] Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
In chronic kidney disease, anemia and disordered iron homeostasis are prevalent and
associated with significant adverse consequences. In 2012, Kidney Disease: Improving …
associated with significant adverse consequences. In 2012, Kidney Disease: Improving …
Safety concerns about intravenous iron therapy in patients with chronic kidney disease
L Del Vecchio, S Longhi, F Locatelli - Clinical Kidney Journal, 2016 - academic.oup.com
Anaemia in chronic kidney disease (CKD) is managed primarily with erythropoiesis-
stimulating agents (ESAs) and iron therapy. Following concerns around ESA therapy …
stimulating agents (ESAs) and iron therapy. Following concerns around ESA therapy …
Assessing iron status: beyond serum ferritin and transferrin saturation
JB Wish - Clinical Journal of the American Society of Nephrology, 2006 - journals.lww.com
The increasing prevalence of multiple comorbidities among anemic patients with chronic
kidney disease has made the use of serum ferritin and transferrin saturation more …
kidney disease has made the use of serum ferritin and transferrin saturation more …
Detection, evaluation, and management of iron-restricted erythropoiesis
LT Goodnough, E Nemeth… - Blood, The Journal of the …, 2010 - ashpublications.org
Progress in our understanding of iron-restricted erythropoiesis has been made possible by
important advances in defining the molecular mechanisms of iron homeostasis. The …
important advances in defining the molecular mechanisms of iron homeostasis. The …
Considerations and challenges in defining optimal iron utilization in hemodialysis
Trials raising concerns about erythropoiesis-stimulating agents, revisions to their labeling,
and changes to practice guidelines and dialysis payment systems have provided strong …
and changes to practice guidelines and dialysis payment systems have provided strong …
Iron toxicity: relevance for dialysis patients
S Fishbane, A Mathew, ND Vaziri - Nephrology Dialysis …, 2014 - academic.oup.com
Iron deficiency is common among patients with advanced kidney disease, particularly those
requiring hemodialysis. Intravenous iron is a convenient treatment to supplement iron and is …
requiring hemodialysis. Intravenous iron is a convenient treatment to supplement iron and is …
Intravenous versus oral iron supplementation for the treatment of anemia in CKD: an updated systematic review and meta-analysis
D Shepshelovich, B Rozen-Zvi, T Avni, U Gafter… - American Journal of …, 2016 - Elsevier
Background Iron supplementation is crucial for the treatment of anemia of chronic kidney
disease (CKD). Although intravenous (IV) iron is preferred for patients with CKD receiving …
disease (CKD). Although intravenous (IV) iron is preferred for patients with CKD receiving …
[HTML][HTML] A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD
DB Van Wyck, M Roppolo, CO Martinez, RM Mazey… - Kidney international, 2005 - Elsevier
A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with
nondialysis-dependent CKD. Background Although iron deficiency frequently complicates …
nondialysis-dependent CKD. Background Although iron deficiency frequently complicates …